Cargando…
Soluble HLA-G is upregulated in serum of patients with severe COVID-19
Soluble HLA-G (sHLA-G) molecules are considered potent immunomodulators, and their dysregulated expression has been implicated in several pathological conditions, including coronavirus disease 19 (COVID-19). Therefore, a case-control study (103 COVID-19 patients and 105 controls) was performed to de...
Autores principales: | Al-Bayatee, Noor T., Ad'hiah, Ali H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282477/ https://www.ncbi.nlm.nih.gov/pubmed/34304938 http://dx.doi.org/10.1016/j.humimm.2021.07.007 |
Ejemplares similares
-
HLA-G 14-bp insertion/deletion polymorphism and risk of coronavirus disease 2019 (COVID-19) among Iraqi patients
por: Ad'hiah, Ali H., et al.
Publicado: (2022) -
Human beta-defensins 2 and 4 are dysregulated in patients with coronavirus disease 19
por: Al-Bayatee, Noor T., et al.
Publicado: (2021) -
Coronavirus disease 19 and risk of hyperglycemia among Iraqi patients
por: Ad’hiah, Ali H., et al.
Publicado: (2021) -
Evaluation of serum soluble HLA-G levels post-recovery from COVID-19 and post-vaccination (Sinopharm and Pfizer-BioNTech)
por: Hamed, Roaa M., et al.
Publicado: (2023) -
Interleukin-37 is down-regulated in serum of patients with severe coronavirus disease 2019 (COVID-19)
por: Ahmed, Aeshah A., et al.
Publicado: (2021)